Pefcalcitol

Drug Profile

Pefcalcitol

Alternative Names: CLS 008; M-5180; M-518101

Latest Information Update: 02 Dec 2016

Price : $50

At a glance

  • Originator Maruho
  • Class Acetamides; Anti-inflammatories; Fluorocarbons; Indenes; Skin disorder therapies; Small molecules; Vitamin D analogues
  • Mechanism of Action Phosphoric diester hydrolase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Palmoplantar keratoderma; Plaque psoriasis

Most Recent Events

  • 17 Nov 2016 Cutanea Life Sciences plans a phase II trial for Plaque psoriasis (In adolescents) in USA (NCT02970331)
  • 20 Apr 2016 Maruho completes a phase III trial for Plaque psoriasis in Japan (Topical) before April 2016 (JapicCTI-152946)
  • 01 Aug 2015 Maruho completes a phase I trial for Healthy volunteers in USA (NCT02256930)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top